Paul Y. Kwo
Palo Alto University(US)Mayo Clinic in Arizona(US)Stanford Medicine(US)Stanford University(US)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Hepatitis C virus research, Liver Disease and Transplantation, Hepatitis B Virus Studies, Organ Transplantation Techniques and Outcomes
Most-Cited Works
- → Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection(2014)1,699 cited
- → Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection(2014)1,302 cited
- → ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries(2016)1,134 cited
- → Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease(2015)798 cited
- → Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus(2010)723 cited
- → Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial(2010)703 cited